Andy Lundin, Author at Gastroenterology Advancements

Transforming Diagnostics: The Role of Next-Generation Sequencing in Gastrointestinal Diseases

Posted by Andy Lundin | Jul 24, 2024 | Genetic Testing |

Next-generation sequencing (NGS) is transforming how clinicians understand, diagnose, and treat a range of gastrointestinal diseases.

Posted by Andy Lundin | Jul 24, 2024 | Laboratory Tests |

The emergence of liquid biopsy technology marks a significant advancement in the early detection and management of gastrointestinal cancers.

The FODMAP diet has become a cornerstone for managing symptoms in patients with IBS and other functional gastrointestinal disorders.

Posted by Andy Lundin | Jul 23, 2024 | Biologic Therapies |

Precision medicine is transforming the management of inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis.

Posted by Andy Lundin | Jul 23, 2024 | Pharma Technology |

The use of biomarkers has revolutionized the approach to treating gastrointestinal disorders, enhancing the effectiveness of pharmacotherapy.